|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Targeted tissue engineering:hydrogels with linear capillary channels for axonal regeneration after spinal cord injury显示文摘Spinal cord injury(SCI)frequently results in the permanent loss of function below the level of injury due to the failure of axonal regeneration in the adult mammalian central nervous system(CNS).The limited intrinsic growth capacity of adult neurons,a lack of growth-promoting factors and the multifactorial inhibitory microenvironment around the lesion site contribute to the lack of | Shengwen Liu Armin Blesch | 2018 | Neural Regeneration Research2018，13，4： | 2 |
| 2 | A neurovascular niche for neurogenesis after stroke显示文摘 | Ohab JJ Fleming S Blesch A | 2006 | J Neurosci2006，26，13： | 1 |
| 3 | Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury显示文摘 | Blesch A Uy HS Grill RJ | 2003 | Neurosci2003，19，9： | 1 |
| 4 | Cellular delivery of neurotrophin- 3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury显示文摘 | Grill R Murai K Blesch A | 1997 | Neurosci1997，17，： | 1 |
| 5 | Clinical pharmacokinetics of capecitabine显示文摘 | Reiger B Blesch KS Weidekamm E | 2001 | Clin Pharmacokinet2001，40，2： | 1 |
| 6 | Nerve growth factor hypersecreting Sehwann cell grafts augment and guide spinal cord axonal growth and remyelinate cenal nervous system axons in a phenotypieally appropriate manner that correlates with expression of L1 显示文摘 | Weidner N Blesch A Grill RJ | 1999 | J Comp Neurol1999，4，： | 1 |
| 7 | Neurotrophism without neurotropism:BDNF promotes survival but not growth of lesioned corticospinal neurons显示文摘 | Lu P Blesch A Tuszynski MH | 2001 | J Comp Neurol2001，436，4： | 1 |
| 8 | Neurotrophic factors,gene therapy,and neural stem cells for spinal cord repair显示文摘 | Blesch A Lu P Tuszynski MH | 2002 | Brain Res Bull2002，57，6： | 1 |
| 9 | Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘 | Gieschke R Reiger B Blesch K S | 2002 | J Pharmacokinet Pharmacodyn2002，29，1： | 1 |
| 10 | Population Pharmacorkinetic analysis of the major metabolites of capecitabine显示文摘 | Reigner B Blesch KS | 2002 | J Pharmacokinet Pharmacodyn2002，29，1： | 1 |
| 11 | Gene therapy and cell transplantation for Alzheimer's disease and spinal cord injury 显示文摘 | Blesch A Tuszynski MH | 2004 | Yonsei ned J2004，45，： | 1 |
| 12 | Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury显示文摘 | Blesch A Uy HS Grill RJ | 1999 | Neurosci1999，19，： | 1 |
| 13 | Clinical pharmacokinetic/pharmacodynamic and physiologically basedpharmacokinetic modeling in new drug development: The capecitabine experience显示文摘 | Blesch KS Gieschke R Tsukamoto Y | 2003 | Investigation New Drugs2003，21，2： | 1 |
| 14 | Population pharmacokinetic analysis of the major metabolites of capecitabine显示文摘 | Gieschike R Reigner B Blesch KS | 2002 | I pharmacokinet pharmacodyn2002，29，1： | 1 |
| 15 | Neurotrophic factors, gene therapy,and neural stem cells for spinal cord repair显示文摘 | Blesch A Lu P Tuszynski | | 0，，： | 1 |
| 16 | Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair 显示文摘 | Blesch A Lu P Tuszynski MH | 2002 | Brain Res Bull2002，57，6： | 1 |
| 17 | S, Gieschke R , Tsukamoto Y, et aLClinical pharmacokinetic/pharmacodynamic and physiologically based pharmacokinetic modeling in new drug develop- ment: the captcitabine experience 显示文摘 | Blesch K | 2003 | lnvest New Drugs2003，21，： | 1 |
| 18 | A neurovascular niche for neurogenesis after stroke显示文摘 | John J Ohab Sheila Fleming Armin Blesch | 2006 | J Neurosci2006，26，13： | 1 |
| 19 | Population pharmacokinetic analysis of the major metabolites of capecitabine 显示文摘 | Gieschke R Reigner B Blesch KS | 2002 | J Pharmacokinet pharmacodyn2002，29，1： | 1 |
| 20 | Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression 显示文摘 | Blesch A Conner JM Tuszynski MH | 2001 | Gene Therapy2001，8，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员